The Von Willebrand factor (VWF) synthesised and secreted by endothelial cells is central to haemostasis and thrombosis, providing a multifunctional adhesive platform that brings together components needed for these processes. VWF secretion can occur from both apical and basolateral sides of endothelial cells, and from constitutive, basal and regulated secretory pathways, the latter two via WeibelPalade bodies (WPB). Although the amount and structure of VWF is crucial to its function, the extent of VWF release, multimerization and polarity of the three secretory pathways have only been addressed separately and with conflicting results. We set out to clarify these relationships using polarized Human Umbilical Vein Endothelial Cells (HUVECs) grown on Transwell membranes. We found the regulated secretion of Ultra large (UL) molecular weight VWF predominantly occurred apically, consistent with a role in localised platelet capture in the vessel lumen. We found that constitutive secretion of low molecular weight (LMW) VWF is targeted basolaterally, toward the subendothelial matrix, using the adaptor protein complex 1 (AP-1), where it may provide the bulk of collagen bound subendothelial VWF. We also found that basally-secreted VWF is composed of UL-VWF, released continuously from WPBs in the absence of stimuli, and occurs predominantly apically, suggesting this could be the main source of circulating plasma VWF.
Introduction
Von Willebrand factor (VWF) is a multimeric adhesive glycoprotein, synthesised and secreted by endothelial cells 1 that is involved in many vascular processes and is central to haemostasis and thrombosis 2 . Circulating plasma and subendothelial VWF, both synthetized by vascular endothelial cells, have been ascribed different roles in haemostasis 3, 4 . How endothelial cells control these two very different functional pools of VWF has not been previously explored.
The multimeric form of secreted VWF largely dictates its haemostatic efficacy, since higher molecular weight VWF multimers have a much higher binding affinity for platelets 5 . Endothelial cells have two differentiated surfaces, apical, facing the vessel lumen, and basolateral facing the subendothelial extracellular matrix. Therefore, to fully understand how and where different multimeric forms of VWF make their contribution, we need to know not only how much is secreted apically versus basolaterally, but also by which one of three pathways it is delivered and the degree of multimerization found in each pool of this protein.
All three secretory pathways begin at the trans-Golgi network (TGN) where VWF is either packaged into nascent Weibel-Palade bodies (WPBs), distinctive rodshaped regulated secretory organelles, or secreted directly through the 'constitutive' secretory pathway by non-descript small anterograde carriers 6 . WPBs store VWF for regulated secretion upon endothelial activation but they can also fuse and release VWF in the absence of activation, a process termed 'basal' secretion to distinguish it from 'constitutive' secretion 7, 8 , although both collect together in the supernatant of unstimulated cells. Low molecular weight -VWF (LMW-VWF) is secreted by the constitutive pathway, in contrast to the HMW-VWF released via stimulated WPBs 6,9 , consistent with the need to control release of highly pro-thrombotic material.
Previous studies have addressed the polarity of VWF secretion, with conflicting results [10] [11] [12] [13] [14] , partly because they were carried out before it was established that there were three pathways for secretion of VWF 8 . van Buul-Wortelboer and collegues 10 used Human Umbilical Vein Endothelial Cells (HUVECs) grown on collagen lattices to show that unstimulated (i.e. basal plus constitutive) VWF release occurs at a 1:3 ratio (apical:basolateral) although the VWF quantified as basolateral release also took into account all the VWF cumulatively bound to the collagen fibres (80%), and so is an overestimation of the true basolateral rate of unstimulated release. When cells were stimulated with phorbol 12-myristate 13-acetate (PMA), most of the VWF was released to the apical side, with no detectable change in the amount released basolaterally. In the same year Sporn and colleagues 11 showed, 15 and apical surfaces 16 . While no comparative analysis was done, this provides confirmation that evoked secretion can occur from both domains.
Altogether, the direction of VWF secretion, by which pathway(s) it is released, and the multimeric state of the releasate at both surfaces are currently unclear. In particular, the relative multimeric state and the polarity of VWF secreted by the basal pathway have never been established. We therefore addressed all these issues together and in parallel.
Finally, the origin of plasma VWF, which is the best characterised pool of this molecule and is the pool assayed for diagnostic purposes, is unclear. While it is expected to be generated from highly multimerized material that is then cleaved by ADAMTS-13 down to the multimeric pattern observed in plasma, whether it arises from basal or regulated exocytosis is yet unclear.
Not only is the basic description of VWF secretion confused, but the machinery for polarized targeting of these pathways in endothelial cells is also poorly understood. Since WPB are the regulated secretory VWF carriers, and AP-1 is essential to their formation 17 , this adaptor protein complex is a strong candidate to be in control of this pathway. Loss of AP-1 also increases unstimulated secretion but whether this is affecting constitutive, basal or both pathways is unclear. Furthermore, AP-1 is thought to mainly play a role in basolateral targeting in polarized epithelial cells 18 and its role in polar trafficking in endothelial cells has never been explored.
Here, we report the polarity and multimeric state of VWF secretion from constitutive, basal and regulated secretory pathways in polarized HUVECs, establish a new role for AP-1 in the constitutive secretion of VWF, and suggest a likely origin for plasma VWF. were used to stimulate regulated release. As previously reported 20, 21 secretagoguestimulated secretion, termed 'regulated' release, was mainly composed of UltraLarge (UL) and very high molecular weight multimers (HMW-VWF), while unstimulated release contained a broad range of multimer sizes including a higher proportion of low molecular weight multimers (LMW-VWF) and prominent dimer bands ( Figure 1A and B). When BFA was used to block constitutive secretion leaving only basal VWF releasate, a multimeric pattern very similar to that of stimulated samples was observed with the exception that a strong dimer band was always present.
Materials & Methods
These patterns suggest that although both are released during unstimulated conditions, constitutive and basally secreted VWF are differently multimerized and so could have very different functions. At the same time, while both believed to arise from WPBs, basal and regulated VWF also have different multimeric patterns, namely the presence of a dimer band in basal secretion, also suggesting a significant difference between these two pools of VWF ( Figure 1C ).
HUVECs form a tight monolayer on Transwell membranes
To study the polarity of VWF secretion, we first established the conditions for 
Constitutive, Basal and Regulated VWF polar release
To measure unstimulated secretion, confluent HUVECs were washed, and incubated in Serum Free medium (SF) for 1 h, and then supernatant collected from the apical and basolateral chambers were assayed for the amount of VWF by ELISA.
We found at least twice as much VWF accumulated apically compared to that released basolaterally, and this ratio was maintained cells grown for several days ( Figure 3A ).
Since VWF secreted with no externally-added stimulant is a mix of constitutive and basal secretory pathways, BFA 8 was used to distinguish between these two pathways. Surprisingly, BFA only reduced basolaterally secreted VWF ( Figure 3B) revealing that most constitutive VWF secretion is directed towards the basolateral side of endothelial cells. Conversely, VWF released during BFA treatment and thus representing basal secretion, is secreted predominantly apically, with only a small fraction secreted basolaterally.
Since we were not expecting a constitutive VWF carrier to be targeted with any particular polarity, we determined if a synthetic secretory cargo lacking any targeting information would also be targeted basolaterally in this cell-system. To address this, HUVECs were transfected with lumGFP 24 , a synthetic cargo that has been shown to be secreted via the constitutive pathway in endothelial cells 25 .
lumGFP secretion from membrane-grown cells was collected from both apical and basolateral chambers and a GFP ELISA showed equal amount of lumGFP released apically and basolaterally ( Figure 3C ). Critically, this release was effectively blocked in both directions by BFA. Since lumGFP is secreted in a non-polarized fashion in polarized endothelial cells, this suggests that normal VWF constitutive secretion is dependent on active sorting into basolaterally-targeted carriers.
In order to establish the polarity of VWF secreted via the regulated pathway, cells on membranes were stimulated with various secretagogues. In all cases, more than 70% of secreted VWF accumulated apically ( Figure 3D ) and this same pattern was unchanged irrespective of how long the cells were grown on filters before assay ( Figure 3E ). As predicted, BFA did not change the pattern of regulated (i.e. Golgi fragmentation in siAP-1M1 treated cells 27, 28 ( Figure S2 ) since we know this would affect WPB biogenesis 29 . Using BFA, we can also now show that most of this increase in unstimulated VWF release in siAP-1M1 treated cells is due to an increase in secretion via the constitutive pathway, since a larger proportion was blocked with BFA ( Figure 4C ). These results confirm that AP-1 is necessary for the sorting of VWF into WPB, and suggest that if this is disrupted, then the displaced VWF is continuously secreted through the constitutive pathway.
In order to determine if AP-1 is also involved in the polarized targeting of VWF from the different secretory pathways, during the second round of siRNA nucleofection HUVECs were seeded onto filters, and allowed to grow for two days.
Importantly, siAP-1M1 treatment did not alter monolayer permeability even after 
Discussion
In this study, we establish for the first time, the relative amounts and multimeric states of VWF released through all three known secretory pathways;
constitutive, basal and regulated release. We show that constitutively secreted VWF is composed of mainly LMW-VWF multimers; that basally secreted VWF, originating from the continuous release of VWF from WPB in the absence of added stimuli, is composed of mostly UL-VWF multimers together with a prominent dimer band; and that regulated VWF release is exclusively composed of UL-VWF multimers ( Figure   1 ). Since the discovery of the basal pathway for VWF secretion from endothelial the relationship between all three pathways and the multimeric state of VWF has not been previously addressed, let alone in a polarized cell system. We have attempted to put all these aspects together into an overall comprehensive picture of polarized VWF secretion and multimerization using primary human endothelial cells.
We find that the largest amount of stimulated (regulated) VWF secretion occurs apically, with varying total amounts depending on the secretagogues used ( Figure 6 ). This is in line with the majority of previous in vitro 10, 12, 14 and in vivo studies 30 . This form of secreted VWF is also composed of mainly UL-VWF multimers. This is in line with the currently accepted, yet experimentally unsupported dogma, that most highly multimerized VWF is secreted mainly towards the apical (lumen) surface of endothelial cells, which we now prove experimentally for the first time. The lumen of the blood vessel is where circulating platelets can be recruited by locally released UL-VWF upon stimulation, and where endothelial-anchored VWF strings can initiate a haemostatic plug, in a tightly localized and controlled fashion 31 .
Thus, regulated VWF release can be thought of as the critical pool for emergency use only, where apically released VWF strings along with basolaterally released anchoring VWF is restricted to the site of injury, while being of the highest plateletbinding activity.
We also find that twice as much unstimulated VWF accumulated apically compared to that released basolaterally, in line with reports from Narahara et al Most in vitro work on exocytosis has focussed on regulated release, and the short collection times (15-60min) used in analyses emphasise the relative amount of secretagogue-driven release, giving the impression of this being the main source of VWF in plasma. However, we suggest that this may be mistaken: if basal release is only 5-20% of secretagogue-driven secretion (depending on the secretagogue used)
per unit time, then for regulated and basal secretion to both generate an equal amount of circulating VWF, 5-20% of the WPB-containing endothelium would need to be activated at any given time-this seems extremely unlikely.
Our data are also consistent with the need for targeting of VWF into WPB for appropriate multimerization to occur during biosynthesis: both regulated and basal pathways release highly multimerized VWF, in contrast to the constitutive pathway.
Why we see a significant dimer band in basally secreted VWF is as yet unclear, although the internal milieu of these two carriers (basal WPBs vs regulated WPBs) are likely to be different, perhaps having different retentions times inside the cell that could potentially drive differential multimerization patterns. Whether the dimers only reflect the differential maturation of the two populations of WPB, or actively contribute to some difference in function is as yet unknown.
Previous findings from our lab (see Supplementary Figure S4C in 29 40 under shear flow, which is critical in producing a haemostatic plug during vascular injury when the entire endothelial layer has been lost and the subendothelial matrix is exposed to shear stress. We note that endothelial cells specifically target this material for incorporation into the matrix via AP-1, implying that this is not non-specific leakage but a deliberate provision of this pool, and that the VWF provided in this way is of low 
